SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-201733
Filing Date
2023-08-02
Accepted
2023-08-02 16:16:19
Documents
15
Period of Report
2023-07-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d483079d8k.htm   iXBRL 8-K 39930
2 EX-10.1 d483079dex101.htm EX-10.1 19284
3 EX-99.1 d483079dex991.htm EX-99.1 12354
7 GRAPHIC g483079g0802073410616.jpg GRAPHIC 5294
  Complete submission text file 0001193125-23-201733.txt   217158

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mtem-20230727.xsd EX-101.SCH 2877
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtem-20230727_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtem-20230727_pre.xml EX-101.PRE 11279
9 EXTRACTED XBRL INSTANCE DOCUMENT d483079d8k_htm.xml XML 3401
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32979 | Film No.: 231135820
SIC: 2834 Pharmaceutical Preparations